Aromatase inhibitor letrozole cuts risk of breast cancer relapse post surgery

Washington, Sept 26 : Scientists have found that aromatase inhibitor letrozole prevents breast cancer recurrences and reduces the risk of death in post-menopausal women with hormone receptor-positive early breast cancer.
Results from the longest-running trial comparing tamoxifen with the aromatase inhibitor letrozole found that if women with early breast cancer were given letrozole after surgery for at least five years, they continued to do better and have fewer recurrences of the disease than those who were given tamoxifen.
"Over a median of eight years of follow-up, women who were assigned to receive five years of letrozole after surgery had an 18 percent reduced risk of relapse and a 21 percent reduced risk of death compared with those assigned to receive tamoxifen," said Professor Richard Gelber, Director of the International Breast Cancer Study Group (IBCSG) Statistical and Data Management Centre at the Dana-Farber Cancer Institute, Boston, MA, USA.
Tamoxifen has been the "gold standard" hormone treatment for women with early, oestrogen-receptor-positive breast cancer and works by blocking the growth-promoting action of oestrogen on the cancer cells.
Aromatase inhibitors, such as letrozole, are newer and alter the function of aromatase, an enzyme involved in oestrogen production.
They can be used in sequence with, or as an alternative to tamoxifen for post-menopausal women.
In the BIG 1-98 trial, researchers enrolled 8,010 patients to receive letrozole and tamoxifen either alone or in sequence, with a total of 4,922 patients included in the monotherapy arms of the study.
This 12-year update shows that, among all 8,010 patients, there were 2,074 relapses and 1,284 deaths, compared with 1,569 relapses and 923 deaths at the ten-year update.
"The data also show that the sequential use of letrozole and tamoxifen (two years of one agent followed by three years of the other) provided similar outcomes compared with five years of letrozole alone for patients who are not at high risk for recurrence," said Prof Gelber. (Agencies)



2011-09-27



blog comments powered by Disqus

Health News 3 Simple Steps to Decreasing Your Risk of Stroke (NewsUSA) - Four out of five victims of a stroke saw no obvious warning signs -- meaning 80 percent of adults who suffered a stroke had no idea they could have managed their risk factors, according to the National Stroke Association. The Centers for Disease Control and Prevention says stroke has become the fourth leading killer in the U.S. If adults can't rely on warning symptoms to point to signs of a stroke, they should take stroke prevention into their own hands. Many of the most significant risk factors are controllable. "Preventive health screening aims to identify those with subclinical disease at a time when lifestyle cha ... Read More

Latest Headlines New Research Collaboration to Target Dementia Free Treatment for Cancer Patients 20pc women osteoporotic by 2015: Study Well-off children also becoming solvent addicts: NGO Step ahead to control Osteoarthritis India's first robotic liver transplant performed Drink black tea to detox, experts tell smokers Exercise as good as drugs in staving off migraines Efficacy of vitamins in improving human health 'questionable', says study

Increase Your Mussel Power in 2012 Essential Foot Care Tips for People With When Meds Cause Constipation, Find the R Drinking Water: An Invaluable Resource T